Penetrating Keratoplasty in Herpes Simplex Disease
暂无分享,去创建一个
[1] P. Ljungman. Prophylaxis against Herpesvirus Infections in Transplant Recipients , 2012, Drugs.
[2] J. Mehta,et al. Outcomes of therapeutic deep lamellar keratoplasty and penetrating keratoplasty for advanced infectious keratitis: a comparative study. , 2009, Ophthalmology (Rochester, Minn.).
[3] P. Charukamnoetkanok,et al. Management of herpes simplex virus stromal keratitis: an evidence-based review. , 2009, Survey of ophthalmology.
[4] H. K. Soong,et al. Femtosecond lasers in ophthalmology. , 2009, American journal of ophthalmology.
[5] D. Coster,et al. Risk Factors for Human Corneal Graft Failure Within the Australian Corneal Graft Registry , 2008, Transplantation.
[6] G. Gerten. Bevacizumab (Avastin) and Argon Laser to Treat Neovascularization in Corneal Transplant Surgery , 2008, Cornea.
[7] J. Mehta,et al. Outcomes of femtosecond laser-assisted penetrating keratoplasty. , 2008, American journal of ophthalmology.
[8] S. Kaufman,et al. Long-term Use of Topical Tacrolimus (FK506) in High-risk Penetrating Keratoplasty , 2008, Cornea.
[9] A. Yoshida,et al. Therapeutic Keratoplasty for Corneal Perforation: Clinical Results and Complications , 2008, Cornea.
[10] H. Taylor,et al. Acyclovir therapy in prevention of recurrent herpetic keratitis following penetrating keratoplasty. , 2008, American journal of ophthalmology.
[11] M. Carrasco. Characteristics and outcomes of adult patients lost to follow-up at an antiretroviral treatment clinic in johannesburg, South Africa , 2008 .
[12] E. Cohen,et al. Trends in penetrating keratoplasty in the United States 1980–2005 , 2008, International Ophthalmology.
[13] P. Rama,et al. Efficacy of valacyclovir vs acyclovir for the prevention of recurrent herpes simplex virus eye disease: a pilot study. , 2007, American journal of ophthalmology.
[14] D. Musch,et al. Effect of Prophylactic Oral Acyclovir After Penetrating Keratoplasty for Herpes Simplex Keratitis , 2007, Cornea.
[15] D. Pavan-Langston,et al. The Boston keratoprosthesis in herpetic keratitis. , 2007, Archives of ophthalmology.
[16] T. Rabsilber,et al. Penetrating keratoplasty using femtosecond laser. , 2007, American journal of ophthalmology.
[17] B. Zuberbuhler,et al. Deep Anterior Lamellar Keratoplasty (DALK): Visual Outcome and Complications for a Heterogeneous Group of Corneal Pathologies , 2007, Cornea.
[18] H. Hosseini,et al. Therapeutic potential of bevacizumab (Avastin) in herpetic stromal keratitis (HSK). , 2007, Medical hypotheses.
[19] Ko-Hua Chen,et al. Herpes simplex keratitis following excimer laser application. , 2006, Journal of refractive surgery.
[20] R. Lapid-Gortzak,et al. Herpes simplex virus keratitis after laser in situ keratomileusis. , 2005, Journal of refractive surgery.
[21] M. Jager,et al. Recurrent herpetic keratitis in penetrating keratoplasty , 2005, Documenta Ophthalmologica.
[22] K. Hayashi,et al. Excimer Laser Photokeratectomy Reactivates Latent Herpes Simplex Virus , 2004, Japanese Journal of Ophthalmology.
[23] E. Godehardt,et al. The influence of glaucoma history on graft survival after penetrating keratoplasty , 1997, Graefe's Archive for Clinical and Experimental Ophthalmology.
[24] Shibo Tang,et al. Clinical and immunohistochemical correlation of herpetic keratitis with the expression of HLA-DR antigen , 1993, Graefe's Archive for Clinical and Experimental Ophthalmology.
[25] C. Foster,et al. Systemic acyclovir and penetrating keratoplasty for herpes simplex keratitis , 2004, Documenta Ophthalmologica.
[26] E. Cohen,et al. Long-term acyclovir use to prevent recurrent ocular herpes simplex virus infection. , 2003, Archives of ophthalmology.
[27] M. Gorin,et al. Fluorescein-Potentiated Argon Laser Therapy Improves Symptoms and Appearance of Corneal Neovascularization , 2002, Cornea.
[28] M. Böhnke,et al. The outcome of corneal grafting in patients with stromal keratitis of herpetic and non-herpetic origin , 2002, The British journal of ophthalmology.
[29] E. Clercq,et al. New treatments for genital herpes. , 2002 .
[30] A. Osterhaus,et al. Corneal herpes simplex virus type 1 superinfection in patients with recrudescent herpetic keratitis. , 2002, Investigative ophthalmology & visual science.
[31] G. Cockerham. Primary graft failure caused by herpes simplex virus type 1. , 2001, Cornea.
[32] B. Rouse,et al. Control of stromal keratitis by inhibition of neovascularization. , 2001, The American journal of pathology.
[33] T. Reinhard,et al. Herpes simplex virus infection in the media of donor corneas during organ culture: Frequency and consequences , 2001, Eye.
[34] Z. Shihab,et al. Herpes simplex virus dermatitis in patients using latanoprost. , 2001, American journal of ophthalmology.
[35] N. Bazan,et al. Effects of topical unoprostone and latanoprost on acute and recurrent herpetic keratitis in the rabbit. , 2001, American journal of ophthalmology.
[36] T. Reinhard,et al. Hochaktive antivirale und immunsuppressive Kombinationstherapie mit Acyclovir und Mycophenolatmofetil nach Keratoplastik bei herpetischer Grunderkrankung , 2001 .
[37] T. Zeyen,et al. Primary Graft Failure Caused by Herpes Simplex Virus Type 1 , 2001, Cornea.
[38] S. Gilbert. Improving the outcome of facial resurfacing--prevention of herpes simplex virus type 1 reactivation. , 2001, The Journal of antimicrobial chemotherapy.
[39] T. Liesegang. Herpes Simplex Virus Epidemiology and Ocular Importance , 2001, Cornea.
[40] E. DiosCastro,et al. [Latanoprost-associated recurrent herpes simplex keratitis]. , 2000 .
[41] G. Cockerham,et al. Primary graft failure : a clinicopathologic and molecular analysis. , 2000, Ophthalmology.
[42] B. MelconSánchez-Friera,et al. Study of infectious keratitis in corneal graft , 2000 .
[43] R. Ayyala,et al. Penetrating keratoplasty and glaucoma. , 2000, Survey of ophthalmology.
[44] Y. Gordon,et al. The Evolution of Antiviral Therapy for External Ocular Viral Infections Over Twenty-five Years , 2000, Cornea.
[45] C. Fletcher,et al. A Risk-Benefit Evaluation of Aciclovir for the Treatment and Prophylaxis of Herpes Simplex Virus Infections , 2000, Drug safety.
[46] S. C. Huang,et al. Microbial keratitis--a late complication of penetrating keratoplasty. , 2000, Transactions of the Royal Society of Tropical Medicine and Hygiene.
[47] M. Boehnke,et al. Effect of Fortified Antibiotic Solutions on Corneal Epithelial Wound Healing , 2000, Cornea.
[48] T. Oshika,et al. A 10-year review of penetrating keratoplasty. , 2000, Japanese journal of ophthalmology.
[49] E. Holland,et al. Oral acyclovir for the management of herpes simplex virus keratitis in children. , 2000, Ophthalmology.
[50] P. Asbell. Valacyclovir for the prevention of recurrent herpes simplex virus eye disease after excimer laser photokeratectomy. , 2000, Transactions of the American Ophthalmological Society.
[51] H. Kaufman,et al. HSV-1 migration in latently infected and naive rabbits after penetrating keratoplasty. , 1999, Investigative ophthalmology & visual science.
[52] F. Wall,et al. Famciclovir as antiviral prophylaxis in laser resurfacing procedures. , 1999, Plastic and reconstructive surgery.
[53] R Neumann,et al. Low-intensity laser therapy is an effective treatment for recurrent herpes simplex infection. Results from a randomized double-blind placebo-controlled study. , 1999, The Journal of investigative dermatology.
[54] Y. Akova,et al. Microbial keratitis following penetrating keratoplasty. , 1999, Ophthalmic surgery and lasers.
[55] H. Thompson,et al. Latanoprost increases the severity and recurrence of herpetic keratitis in the rabbit. , 1999, American journal of ophthalmology.
[56] T. Liesegang,et al. Latanoprost and herpes simplex keratitis. , 1999, American journal of ophthalmology.
[57] E. Cohen,et al. Oral acyclovir after penetrating keratoplasty for herpes simplex keratitis. , 1999, Archives of ophthalmology.
[58] Y. Akova,et al. Efficacy of low-dose and long-term oral acyclovir therapy after penetrating keratoplasty for herpes simplex heratitis. , 1999, Ocular immunology and inflammation.
[59] G. Naumann,et al. Infection of the corneal endothelium in herpes simplex keratitis. , 1998, American journal of ophthalmology.
[60] R. D. Stulting,et al. Acyclovir for the prevention of recurrent herpes simplex virus eye disease. Herpetic Eye Disease Study Group. , 1998, The New England journal of medicine.
[61] E. Romanowski,et al. Efficient reactivation of latent herpes simplex virus type 1 infection by excimer laser keratectomy in the experimental rabbit ocular model. , 1998, American journal of ophthalmology.
[62] D. Larkin. Corneal transplantation for herpes simplex keratitis , 1998, The British journal of ophthalmology.
[63] E. Cohen,et al. Indications for penetrating keratoplasty and associated procedures, 1989-1995. , 1997, Cornea.
[64] A. Slomovic,et al. Indications for penetrating keratoplasty in Canada, 1986-1995. , 1997, Cornea.
[65] E. Cohen,et al. Ulcerative keratitis in bullous keratopathy. , 1997, Ophthalmology.
[66] G. Cockerham,et al. Herpes simplex virus in primary graft failure. , 1997, Archives of ophthalmology.
[67] P. Doornenbal,et al. Newly acquired herpes simplex virus keratitis after penetrating keratoplasty. , 1997, Ophthalmology.
[68] J. Nicolas,et al. Effect of laser irradiation on latency of herpes simplex virus in a mouse model. , 1997, Pathologie-biologie.
[69] C. Siganos,et al. Thirty years of penetrating keratoplasty in Israel. , 1997, Cornea.
[70] S. Kinoshita,et al. Polymerase chain reaction detection of herpes simplex virus in tear fluid from atypical herpetic epithelial keratitis after penetrating keratoplasty. , 1996, American journal of ophthalmology.
[71] R. D. Stulting,et al. Risk factors for herpes simplex virus epithelial keratitis recurring during treatment of stromal keratitis or iridocyclitis. Herpetic Eye Disease Study Group. , 1996, The British journal of ophthalmology.
[72] M. Lynn,et al. Donor factors associated with epithelial defects after penetrating keratoplasty. , 1996, Cornea.
[73] P. Klapper,et al. Detection of herpes simplex virus DNA in donor cornea culture medium by polymerase chain reaction. , 1996, The British journal of ophthalmology.
[74] D. Easty,et al. Recurrent herpes simplex after corneal transplantation in rats. , 1996, Investigative ophthalmology & visual science.
[75] Hill Jc. The relative importance of risk factors used to define high-risk keratoplasty. , 1996 .
[76] N. Ehlers,et al. Recurrence and rejection rates following corneal transplantation for herpes simplex keratitis. , 2009, Acta ophthalmologica Scandinavica.
[77] S. Li,et al. [Detection of herpes viral genome in corneal buttons of quiescet herpes simplex keratitis with polymerase chain reaction]. , 1995, Yan ke xue bao = Eye science.
[78] J. Gottsch,et al. Persisting epithelial herpes simplex keratitis while on cyclosporin-A ointment. , 1995, Australian and New Zealand journal of ophthalmology.
[79] J. Sugar,et al. The indications for and outcome in pediatric keratoplasty. A multicenter study. , 1995, Ophthalmology.
[80] J. Niland,et al. Herpes simplex Virus dna in normal corneas: Persistence without viral shedding from ganglia , 1995, Journal of medical virology.
[81] C. K. Cheng,et al. Acyclovir treatment for linear endotheliitis on grafted corneas. , 1995, Cornea.
[82] R. D. Stulting,et al. Risk factors for corneal graft failure and rejection in the collaborative corneal transplantation studies. Collaborative Corneal Transplantation Studies Research Group. , 1994, Ophthalmology.
[83] P. Klapper,et al. Corneal Donor Infection by Herpes Simplex Virus: Herpes Simplex Virus DNA in Donor Corneas , 1994, Cornea.
[84] N. Barney,et al. A Prospective Randomized Trial of Oral Acyclovir After Penetrating Keratoplasty for Herpes Simplex Keratitis , 1994, Cornea.
[85] D. Musch,et al. Antiviral therapy after penetrating keratoplasty for herpes simplex keratitis. , 1994, Archives of ophthalmology.
[86] G. Stern,et al. Results of therapeutic penetrating keratoplasty. , 1993, Ophthalmology.
[87] R. D. Stulting,et al. Herpes simplex virus type 1 transcription is not detectable in quiescent human stromal keratitis by in situ hybridization. , 1993, Investigative ophthalmology & visual science.
[88] S. Spruance. Prophylactic chemotherapy with acyclovir for recurrent herpes simplex labialis , 1993, Journal of medical virology.
[89] Y. Mori,et al. Herpes simplex virus latency in human cornea. , 1993, Japanese journal of ophthalmology.
[90] R. Frothingham,et al. Acyclovir-resistant herpes simplex virus keratouveitis after penetrating keratoplasty. , 1992, Ophthalmology.
[91] N. Maitland,et al. Latency-associated transcripts in corneas and ganglia of HSV-1 infected rabbits. , 1991, The British journal of ophthalmology.
[92] S. Cook,et al. Herpes simplex virus: molecular biology and the possibility of corneal latency. , 1991, Survey of ophthalmology.
[93] D. Coster,et al. Long-term outcome after corneal transplantation. Visual result and patient perception of success. , 1991, Ophthalmology.
[94] H. Kaufman,et al. Herpes simplex dendritic keratitis after keratoplasty. , 1991, American journal of ophthalmology.
[95] S. Kaye,et al. Evidence for herpes simplex viral latency in the human cornea. , 1991, The British journal of ophthalmology.
[96] H. Kaufman,et al. Herpes simplex dendritic keratitis after keratoplasty. , 1991, American journal of ophthalmology.
[97] A. Steele,et al. Is raised intraocular pressure a bad prognostic sign in acute corneal graft rejection? , 1991, Eye.
[98] W. Aclimandos,et al. Sclerokeratitis after keratoplasty in atopy. , 1990, Ophthalmology.
[99] J. Niederkorn. Immune privilege and immune regulation in the eye. , 1990, Advances in immunology.
[100] A. Steele,et al. Microbial keratitis after penetrating keratoplasty , 1990, Eye.
[101] L. Ficker,et al. The changing management and improved prognosis for corneal grafting in herpes simplex keratitis. , 1989, Ophthalmology.
[102] A. Steele,et al. The management of post-keratoplasty glaucoma by trabeculectomy , 1989, Eye.
[103] M. Arens,et al. Oral acyclovir reduces the incidence of recurrent herpes simplex keratitis in rabbits after penetrating keratoplasty. , 1989, Archives of ophthalmology.
[104] R. J. Mack,et al. An in vitro analysis of aminoglycoside corneal epithelial toxicity. , 1989, Current eye research.
[105] A. Steele,et al. Longterm prognosis for corneal grafting in herpes simplex keratitis , 1988, Eye.
[106] R. D. Stulting,et al. Laser trabeculoplasty for glaucoma in aphakic and pseudophakic eyes after penetrating keratoplasty. , 1988, Archives of ophthalmology.
[107] J. Jester,et al. Return of human corneal sensitivity after penetrating keratoplasty. , 1988, Archives of ophthalmology.
[108] R. D. Stulting,et al. Penetrating keratoplasty for herpes simplex keratitis and keratoconus. Allograft rejection and survival. , 1987, Ophthalmology.
[109] Ormerod Ld,et al. Contact lens-associated microbial keratitis. , 1986 .
[110] A. Sugar,et al. A Randomized Trial of Topical Corticosteroids in Epithelial Healing after Keratoplasty , 1984, Cornea.
[111] H. Völker‐Dieben,et al. THE EFFECT OF PROSPECTIVE HLA‐A AND ‐B MATCHING IN 288 PENETRATING KERATOPLASTIES FOR HERPES SIMPLEX KERATITIS , 1984, Acta ophthalmologica.
[112] J. D. Salisbury,et al. Herpesvirus infection of cornea allografts. , 1984, Ophthalmic surgery.
[113] A. Sugar,et al. A randomized trial of pressure patching for epithelial defects after keratoplasty. , 1983, American journal of ophthalmology.
[114] E. Cohen,et al. Corneal transplantation for herpes simplex keratitis. , 1983, American journal of ophthalmology.
[115] A. E. Maumenee,et al. Combined keratoplasty, cataract extraction, and intraocular lens implantation: experience at the Wilmer Institute. , 1981, Ophthalmic surgery.
[116] C. Foster,et al. Penetrating keratoplasty for herpes simplex keratitis. , 1981, American journal of ophthalmology.
[117] J. Krachmer,et al. Clinical types of corneal transplant rejection. Their manifestations, frequency, preoperative correlates, and treatment. , 1981, Archives of ophthalmology.
[118] D. Coster,et al. Prognosis and management of corneal transplantation for herpetic keratitis. , 1980, Archives of ophthalmology.